HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rossana M C Pereira Selected Research

somatotropin releasing hormone receptor

9/2014Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification.
9/2014Liver status in congenital, untreated, isolated GH deficiency.
11/2013Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone.
8/2013Prolactin and sex steroids levels in congenital lifetime isolated GH deficiency.
6/2013Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.
9/2012The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance.
6/2012Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency.
2/2010Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.
7/2008Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene.
6/2007Heterozygosity for a mutation in the growth hormone-releasing hormone receptor gene does not influence adult stature, but affects body composition.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rossana M C Pereira Research Topics

Disease

14Pituitary Dwarfism
09/2014 - 07/2002
5Insulin Resistance
06/2013 - 06/2007
4Atherosclerosis
09/2014 - 12/2007
1Non-alcoholic Fatty Liver Disease
09/2014
1Genu Valgum
11/2013
1Glucose Intolerance
06/2013
1Atherosclerotic Plaque (Atheroma)
06/2012
1Hypercholesterolemia
02/2010
1Hypopituitarism (Sheehan's Syndrome)
07/2009
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
02/2009

Drug/Important Bio-Agent (IBA)

11somatotropin releasing hormone receptorIBA
09/2014 - 04/2007
5Hormones (Hormone)IBA
09/2014 - 07/2002
3Growth Hormone (Somatotropin)IBA
03/2014 - 04/2007
3Glucose (Dextrose)FDA LinkGeneric
06/2013 - 03/2012
3Insulin (Novolin)FDA Link
09/2012 - 06/2007
3Insulin-Like Growth Factor I (IGF-1)IBA
09/2012 - 06/2007
2C-Reactive ProteinIBA
02/2010 - 07/2008
1Transaminases (Aminotransferases)IBA
09/2014
1SteroidsIBA
08/2013
1ProlactinIBA
08/2013
1OsteocalcinIBA
09/2012
1glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA
09/2012
1AlbuminsIBA
02/2010
1AdipokinesIBA
02/2010
1Steroid 21-Hydroxylase (21 Hydroxylase)IBA
02/2009
1CholesterolIBA
07/2008
1LDL CholesterolIBA
07/2008